NCT05398055View on ClinicalTrials.gov

Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever

PHASE3RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Rocky Mountain Spotted Fever
Interventions
DRUG

Azithromycin + Doxycycline

azithromycin 500 mg orally every 24 hours for three dose plus doxycycline 100 mg orally every 12 hours for 7 days

DRUG

Placebo + Doxycycline

doxycycline 100 mg orally every 12 hours for 7 days plus placebo 1 capsule every 24 hours, 3 doses

Trial Locations (1)

21000

RECRUITING

Hospital General de Mexicali, Mexicali

All Listed Sponsors
lead

Hospital General de Mexicali

OTHER